Marie Laure Bonnet

Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia

Stéphane Flamant, William Ritchie, Joëlle Guilhot et al. · Haematologica · 2010 · 116 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation

Jean‐Claude Chomel, Marie Laure Bonnet, Nathalie Sorel et al. · Oncotarget · 2016 · 63 citations · Full text

Medicine, Hematology, Pharmacology +16

Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cells

Paul Coppo, Isabelle Dusanter‐Fourt, Gaël A. Millot et al. · Oncogene · 2003 · 57 citations

Life Sciences, Cell Biology, Molecular Biology +13

Evidence of ABL-kinase domain mutations in highly purified primitive stem cell populations of patients with chronic myelogenous leukemia

Nathalie Sorel, Marie Laure Bonnet, Martine Guillier et al. · Biochemical and Biophysical Research Communications · 2004 · 53 citations

Life Sciences, Cell Biology, Hematology +13

Tyrosine kinase inhibitor AG1024 exerts antileukaemic effects on STI571-resistant Bcr-Abl expressing cells and decreases AKT phosphorylation

Éric Deutsch, Laurence Maggiorella, Bei Wen et al. · British Journal of Cancer · 2004 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17